Literature DB >> 31309396

Breast pain and cancer: should we continue to work-up isolated breast pain?

Marina Mohallem Fonseca1, Leslie R Lamb2, Raman Verma2, Olaitan Ogunkinle2, Jean M Seely2.   

Abstract

PURPOSE: To assess the cancer detection rate (CDR) in patients presenting with isolated breast pain.
METHODS: A retrospective review was performed of consecutive patients presenting to a large tertiary care academic center or an affiliated hospital with isolated breast pain from October 1, 2013 to September 30, 2015. Medical records were reviewed for patient demographics, pain characteristics, imaging findings, and outcome.
RESULTS: The study cohort was comprised of 971 exams in 953 patients, with a median age of 50 years. A total of 62.5% (607/971) of the cases were assessed by mammography and ultrasound, 24.4% (237/971) by ultrasound only, and 13.1% (127/971) by mammography only. Including the abnormalities detected in the asymptomatic breast, 88.7% (861/971) of the cases were negative or had benign findings (BI-RADS 1 and 2), 6.8% (66/971) were probably benign (BI-RADS 3), 3.9% (38/971) were suspicious (BI-RADS 4), and 0.6% (6/971) were highly suggestive of malignancy (BI-RADS 5). CDR on initial work-up was 0.8% (8/953), of which 0.6% (4/690) was in average-risk patients while 1.5% (4/263) was in higher-than-average risk patients.
CONCLUSIONS: CDR in patients presenting with isolated breast pain overall was low, comparable to the expected incidence of breast cancer in asymptomatic women. Work-up for isolated breast pain may therefore be unnecessary and lead to overutilization of healthcare resources. Routine screening mammography should be encouraged and higher-than-average risk patients may benefit from additional tests.

Entities:  

Keywords:  Breast; Cancer; Mastalgia; Pain

Mesh:

Year:  2019        PMID: 31309396     DOI: 10.1007/s10549-019-05354-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  1 in total

1.  Transforming the 2-week wait (2WW) pathway: management of breast pain in primary care.

Authors:  Mohamed Jahan; Thilan Bartholomeuz; Nikki Milburn; Veronica Rogers; Mark Sibbering; John Robertson
Journal:  BMJ Open Qual       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.